Sarepta Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $43.5M, a 9.56% decline year-over-year.
  • Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $180M, a 3.68% decline year-over-year.
  • Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $183M, a 21.7% decline from 2022.
  • Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $233M, a 105% increase from 2021.
  • Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $114M, a 5.43% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $183M -$50.5M -21.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $233M +$119M +105% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $114M +$5.87M +5.43% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $108M +$29.5M +37.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $78.6M +$28.5M +56.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $50.1M +$19.7M +64.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $30.5M +$503K +1.68% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $30M -$2.16M -6.71% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $32.1M +$11.8M +57.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $20.3M +$9.22M +82.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $11.1M +$8.05M +262% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 $3.08M -$51K -1.63% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 $3.13M -$40K -1.26% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 $3.17M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.